Latest News

ASH 2019 myeloma highlights

December 10, 2019

More than 900 myeloma abstracts (posters and oral sessions) were presented in the largest world congress of hematology: the American Society of Hematology (ASH) Annual Meeting 2019 that was held from 7 to 10 December…

Myeloma ASH 2019 preview

November 27, 2019

More than 900 myeloma abstracts (posters and oral sessions) will be presented in the largest world congress of hematology: the American Society of Hematology (ASH) Annual Meeting 2019 that will be held from 7…

ASCO 2019 – Lenalidomide reduces risk that smoldering myeloma will progress to myeloma in high risk patients

May 31, 2019

The phase II/III E3A06 randomized clinical trial found that lenalidomide (Revlimid) significantly reduces the risk of smoldering multiple myeloma (SMM) — a precancerous condition — from progressing to cancer in patients at moderate or…

ASH 2018 highlights in myeloma

February 12, 2019

Myeloma Patients Europe held a webinar to review the most recent myeloma findings presented at the annual meeting of the American Society of Hematology (ASH) that took place in San Diego (California, United States) in…

MPE will hold a webinar on ASH 2018 highlights in myeloma and AL amyloidosis

January 16, 2019

Myeloma Patients Europe will hold a webinar to review the most recent myeloma findings presented at the annual meeting of the American Society of Hematology (ASH) that took place in San Diego (California, United States)…

New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myeloma

December 4, 2018

Initial data from the ongoing phase I clinical trial of bb21217 (CRB-402) were presented at the 60th Annual Meeting of the American Society of Hematology (ASH). This is an investigational next-generation anti-BCMA CAR T cell…

ASH 2018 is about to kick-off in San Diego, USA

November 26, 2018

The annual meeting of the American Society of Haematology (ASH) 2018 starts this week (between 1 and 4 December) in San Diego, California.

Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risks

October 11, 2018

Complementary and alternative medicines are used by 1 in 2 patients before and during cancer treatments, however they are frequently associated with drug-drug interactions, a estudy at ESMO 2018 report.

September

October 2025

November

MO
TU
WE
TH
FR
SA
SU

29
30
1
2
3
4
5

6
7
8
9
10
11
12

13
14
15
16
17
18
19

20
21
22
23
24
25
26

27
28
29
30
31
1
2

Events for October

31st

No Events

Latest News

October 2025

Events for October

1st

Events for October

2nd

Events for October

3rd

Events for October

4th

Events for October

5th

Events for October

6th

Events for October

7th

Events for October

8th

Events for October

9th

Events for October

10th

Events for October

11th

Events for October

12th

Events for October

13th

Events for October

14th

Events for October

15th

Events for October

16th

Events for October

17th

Events for October

18th

Events for October

19th

Events for October

20th

Events for October

21st

Events for October

22nd

Events for October

23rd

Events for October

24th

Events for October

25th

Events for October

26th

Events for October

27th

Events for October

28th

Events for October

29th

Events for October

30th

Events for October

31st

PopUp